Benjamin Steil

Benjamin Steil is an experienced professional in the fields of molecular biology and immunology, currently serving as Research, Development, and Applications Manager at Daicel Arbor Biosciences since May 2015, where responsibilities include the research and development of innovative products for next generation sequencing and synthetic biology leveraging an in-house DNA and RNA synthesis platform. Previously, Benjamin Steil worked at Global Vaccines, Inc. from August 2008 to June 2014 as a Staff Scientist, focusing on the production of a VEE virus-derived adjuvant and the design of an RNA expression system, along with serving as a Postdoctoral Fellow conducting significant research on innate immune responses. Educational credentials include a Ph.D. in Microbiology and Immunology from the University of Colorado Denver and a Bachelor of Arts in Chemistry from Saint John's University.